Healthy.io builds smartphone-powered clinical-grade diagnostics and care tools, including an FDA-cleared at-home kidney test called Minuteful Kidney and smartphone-enabled wound imaging using computer vision. The company’s at-home urinalysis services and patient engagement tools are marketed commercially across the United States and the United Kingdom and are integrated with health insurers and providers. Healthy.io’s products enable clinicians to monitor high‑risk patients remotely, provide timely clinical data and visual wound records, and help close care gaps and reduce deterioration and amputations. Led by CEO and founder Yonatan Adiri, the company partners with health plans, health systems, and kidney care management groups to deploy its Minuteful Kidney service. The company also offers wound image technology to digitize chronic wound management. Healthy.io is based in Boston, MA; London, UK; and Tel Aviv, Israel. Healthy.io develops smartphone-based clinical diagnostic tools that use the phone camera as a medical device, beginning with an FDA- and European-cleared smartphone urinalysis. Its first offering has been used by tens of thousands of patients across a range of smartphones. The company also received FDA 510(k) clearance for a smartphone-based albumin-to-creatinine ratio (ACR) test to aid chronic kidney disease diagnosis. Healthy.io partners with health-care and technology organizations including Siemens, Samsung, the UK National Health Service, Geisinger Health, Johns Hopkins University and the US National Kidney Foundation. The company plans to accelerate global expansion and further product development using the newly raised capital. Yonatan Adiri is founder and CEO, and the company added industry veteran Gary Loveman to its board to advise U.S. activities. Healthy.io has developed a smartphone urinalysis platform—an FDA- and CE-cleared home urine test that uses a smartphone camera to scan dipsticks and send results directly to clinicians, integrated with medical records. The company positions this “medical selfie” to shift clinical-grade urinalysis from labs to patients' homes and to improve early detection of kidney disease. Its digital urinalysis pathway is already being used by more than 100,000 patients through partnerships with organizations including Siemens Healthineers, the UK National Health Service, the US National Kidney Foundation, Geisinger Health, Clalit, Maccabi, and Meuhedet. Clinical assessments with Geisinger and the US National Kidney Foundation showed a 71% adherence rate among previously untested hypertensive patients; in the UK rollout 10% of patients tested positive for elevated protein, indicating previously unknown kidney disease. CEO Yonatan Adiri says Healthy.io operates a “pay per protein” model and aims to reduce costs for strained medical systems while preventing kidney disease complications. Recently the company raised $18 million in a Series B to help scale its home testing service in the U.S. and U.K.

Total raised

$128M

Funding rounds

3

Latest round

Series D

Latest activity

May 2023